Histone deacetylase class II and acetylated core histone immunohistochemistry in human brains with Huntington's disease

Brain Research

Volumn 1504, Issue , 2013, Pages 16-24

  Yeh, Hsin Hsien ^a,c   Young, Daniel ^c   Gelovani, Juri G ^c   Robinson, Andrew ^b   Davidson, Yvonne ^b   Herholz, Karl ^a,b   Mann, David M A ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Acetylated histone; Histone deacetylase; Huntington's disease; Immunohistochemistry

Indexed keywords

HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 5; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4;

ARTICLE; BRAIN; CAUDATE NUCLEUS; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL;

ACETYLATION; ADULT; AGED; AGED, 80 AND OVER; BRAIN; FEMALE; HISTONE DEACETYLASE 2; HISTONES; HUMANS; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED;

ANIMALIA;

EID: 84875228213     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.02.012     Document Type: Article

References (22)

1. T. Abel, and R.S. Zukin Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders Curr. Opin. Pharmacol. 8 2008 57 64
2. M. Baker, I.R. Mackenzie, S.M. Pickering-Brown, J. Gass, R. Rademakers, C. Lindholm, J. Snowden, J. Adamson, A.D. Sadovnick, S. Rollinson, A. Cannon, E. Dwosh, D. Neary, S. Melquist, A. Richardson, D. Dickson, Z. Berger, J. Eriksen, T. Robinson, C. Zehr, C.A. Dickey, R. Crook, E. McGowan, D. Mann, B. Boeve, H. Feldman, and M. Hutton Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 Nature 442 2006 916 919
3. R.S. Broide, J.M. Redwine, N. Aftahi, W. Young, F.E. Bloom, and C.J. Winrow Distribution of histone deacetylases 1-11 in the rat brain J. Mol. Neurosci. 31 2007 47 58
4. R. Butler, and G.P. Bates Histone deacetylase inhibitors as therapeutics for polyglutamine disorders Nat. Rev. Neurosci. 7 2006 784 796
5. S. Chawla, P. Vanhoutte, F.J. Arnold, C.L. Huang, and H. Bading Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5 J. Neurochem. 85 2003 151 159
6. J.P. Dompierre, J.D. Godin, B.C. Charrin, F.P. Cordelieres, S.J. King, S. Humbert, and F. Saudou Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation J. Neurosci. 27 2007 3571 3583
7. S.E. Dougherty, J.L. Reeves, E.K. Lucas, K.L. Gamble, M. Lesort, and R.M. Cowell Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington Disease Exp. Neurol. 236 2012 171 178
8. R.J. Ferrante, J.K. Kubilus, J. Lee, H. Ryu, A. Beesen, B. Zucker, K. Smith, N.W. Kowall, R.R. Ratan, R. Luthi-Carter, and S.M. Hersch Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice J. Neurosci. 23 2003 9418 9427
9. E. Hockly, V.M. Richon, B. Woodman, D.L. Smith, X. Zhou, E. Rosa, K. Sathasivam, S. Ghazi-Noori, A. Mahal, P.A.S. Lowden, J.S. Steffan, J.L. Marsh, L.M. Thompson, C.M. Lewis, P.A. Marks, and G.P. Bates Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease Proc. Natl. Acad. Sci. 100 2003 2041
10. M. Hoshino, K. Tagawa, T. Okuda, M. Murata, K. Oyanagi, N. Arai, T. Mizutani, I. Kanazawa, E.E. Wanker, and H. Okazawa Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein J. Neurochem. 87 2003 257 267
11. D.A. Linseman, C.M. Bartley, S.S. Le, T.A. Laessig, R.J. Bouchard, M.K. Meintzer, M. Li, and K.A. Heidenreich Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+)//calmodulin- dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival J. Biol. Chem. 278 2003 41472 41481
12. R. Luthi-Carter, A. Strand, N.L. Peters, S.M. Solano, Z.R. Hollingsworth, A.S. Menon, A.S. Frey, B.S. Spektor, E.B. Penney, G. Schilling, C.A. Ross, D.R. Borchelt, S.J. Tapscott, A.B. Young, J.H. Cha, and J.M. Olson Decreased expression of striatal signaling genes in a mouse model of Huntington's disease Hum. Mol. Genet. 9 2000 1259 1271
13. J. Pallos, L. Bodai, T. Lukacsovich, J.M. Purcell, J.S. Steffan, L.M. Thompson, and J.L. Marsh Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease Hum. Mol. Genet. 17 2008 3767 3775
14. S.M. Pickering-Brown Review: Recent progress in frontotemporal lobar degeneration Neuropathol. Appl. Neurobiol. 36 2010 4 16
15. L. Quinti, V. Chopra, D. Rotili, S. Valente, A. Amore, G. Franci, S. Meade, M. Valenza, L. Altucci, M.M. Maxwell, E. Cattaneo, S. Hersch, A. Mai, and A. Kazantsev Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model PLoS Curr. 2010 2
16. U. Rub, F. Hoche, E.R. Brunt, H. Heinsen, K. Seidel, D. Del Turco, H.L. Paulson, J. Bohl, C. von Gall, J.P. Vonsattel, H.W. Korf, and W.F. den Dunnen Degeneration of the cerebellum in Huntington's Disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process Brain Pathol. 2012
17. G. Sadri-Vakili, and J.H. Cha Histone deacetylase inhibitors: a novel therapeutic approach to Huntington's disease (complex mechanism of neuronal death) Curr. Alzheimer Res. 3 2006 403 408
18. G. Sadri-Vakili, B. Bouzou, C.L. Benn, M.O. Kim, P. Chawla, R.P. Overland, K.E. Glajch, E. Xia, Z. Qiu, S.M. Hersch, T.W. Clark, G.J. Yohrling, and J.H. Cha Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models Hum. Mol. Genet. 16 2007 1293 1306
19. T. Schweder, and E. Spjotvoll Plots of P-values to evaluate many tests simultaneously Biometrika 69 1982 493 502
20. J.S. Snowden, S. Rollinson, J.C. Thompson, J.M. Harris, C.L. Stopford, A.M. Richardson, M. Jones, A. Gerhard, Y.S. Davidson, A. Robinson, L. Gibbons, Q. Hu, D. DuPlessis, D. Neary, D.M. Mann, and S.M. Pickering-Brown Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations Brain 135 2012 693 708
21. J.S. Steffan, A. Kazantsev, O. Spasic-Boskovic, M. Greenwald, Y.Z. Zhu, H. Gohler, E.E. Wanker, G.P. Bates, D.E. Housman, and L.M. Thompson The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription Proc. Natl. Acad. Sci. USA 97 2000 6763 6768
22. J.S. Steffan, L. Bodai, J. Pallos, M. Poelman, A. McCampbell, B.L. Apostol, A. Kazantsev, E. Schmidt, Y.Z. Zhu, M. Greenwald, R. Kurokawa, D.E. Housman, G.R. Jackson, J.L. Marsh, and L.M. Thompson Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila Nature 413 2001 739 743